Sign In

Robert Glassman

Robert Glassman, M.D. is a seasoned healthcare executive with nearly 30 years of experience in healthcare leadership and investment.2 He has been serving as an independent, non-executive director on the Board of Jubilant Therapeutics since February 1, 2021.3

Dr. Glassman's current roles include:

  1. Executive Vice President, Search & Evaluation at Enavate Sciences (since July 2022)26
  2. Director at Pharvaris NV (since January 2021)12
  3. Board member at Umoja Biopharma25
  4. Board member at Portage Biotech26
  5. Clinical Assistant Professor at Weill Cornell Medical College17

His previous positions include:

  • Vice Chairman & Managing Director at Credit Suisse Securities (USA) LLC (2015-2021)16
  • Managing Director at Bank of America Merrill Lynch (2010-2015)1
  • Partner at OrbiMed Advisors (2009-2010)14

Dr. Glassman holds an AB magna cum laude from Harvard College and an MD from Harvard Medical School.4 He is a board-certified hematologist-oncologist and has authored numerous articles in peer-reviewed journals.47

Highlights

Dec 5 · pharvaris.com
Robert Glassman, M.D. - Director - Pharvaris
Enavate Sciences Appoints Industry Veteran Robert Glassman as ...
Umoja Biopharma Appoints Dr. Robert Glassman to its Board of ...
Jul 23 · marketscreener.com
Robert Glassman: Positions, Relations and Network - MarketScreener

Related Questions

What are Robert Glassman's main responsibilities at Jubilant Therapeutics?
How has Robert Glassman's background in oncology influenced his work at Jubilant Therapeutics?
What are some of the key projects Robert Glassman has been involved in at Pharvaris?
How did Robert Glassman transition from investment banking to biopharma leadership?
What is Robert Glassman's role at Enavate Sciences, and how does it complement his work at Jubilant Therapeutics?
Robert Glassman
Add to my network

Location

Maplewood, New Jersey, United States